Enliven Therapeutics Inc (ELVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ELVN | SPRY | ARDX | ||
| Company | Enliven Therapeutics Inc | Ars Pharmaceuticals Inc | Ardelyx Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 24.90 | 13.70 | 4.93 | ||
| High | 25.76 | 14.28 | 4.96 | ||
| Low | 24.52 | 13.50 | 4.67 | ||
| Last | 25.14 | 14.14 | 4.75 | ||
| Change | +0.24 | +0.36 | -0.21 | ||
| % Change | +0.96% | +2.61% | -4.23% | ||
| Volume | 104,375 | 281,835 | 1,714,848 | ||
| 20-Day Average Volume | 244,101 | 1,262,239 | 5,530,299 | ||
| Previous Close | 24.90 | 13.78 | 4.96 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 27.54 | 15.21 | 5.49 | ||
| 20-Day Raw Stochastic | 21.28% | 15.15% | 18.25% | ||
| 20-Day Relative Strength | 41.38% | 46.58% | 39.17% | ||
| Weighted Alpha | +33.59 | +149.33 | -28.13 | ||
| Today's Opinion | 56% Buy | 64% Buy | 88% Sell | ||
| Previous Opinion | 56% Buy | 64% Buy | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 48% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.01% since 11/12/24 | -14.87% since 11/12/24 | +3.27% since 11/12/24 | ||
| Low | 23.70 on 11/15/24 | 13.36 on 11/15/24 | 4.43 on 11/14/24 | ||
| High | 27.59 on 11/13/24 | 16.51 on 11/13/24 | 5.06 on 11/18/24 | ||
| 1-Month | |||||
| %Chg | -13.81% since 10/18/24 | -11.57% since 10/18/24 | -18.84% since 10/18/24 | ||
| Low | 23.70 on 11/15/24 | 13.36 on 11/15/24 | 4.34 on 11/11/24 | ||
| High | 29.78 on 11/07/24 | 18.51 on 11/11/24 | 6.53 on 11/07/24 | ||
| 3-Month | |||||
| %Chg | +6.23% since 08/19/24 | -0.70% since 08/19/24 | -20.87% since 08/19/24 | ||
| Low | 21.34 on 08/30/24 | 11.00 on 09/06/24 | 4.34 on 11/11/24 | ||
| High | 30.03 on 10/18/24 | 18.51 on 11/11/24 | 7.18 on 09/27/24 | ||
| 6-Month | |||||
| %Chg | +8.49% since 05/17/24 | +56.59% since 05/17/24 | -39.31% since 05/17/24 | ||
| Low | 19.52 on 06/07/24 | 7.55 on 06/25/24 | 4.34 on 11/11/24 | ||
| High | 30.03 on 10/18/24 | 18.51 on 11/11/24 | 8.06 on 07/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,216,589 | 1,339,209 | 1,174,796 | ||
| Shares Outstanding, K | 48,859 | 97,185 | 236,854 | ||
| Annual Sales | 0 | 30,000 | 124,460,000 | ||
| Annual Net Income | -71,580,000 | -54,370,000 | -66,070,000 | ||
| Last Quarter Sales | 0 | 2,070,000 | 98,240,000 | ||
| Last Quarter Net Income | -23,160,000 | -19,130,000 | -810,000 | ||
| 60-Month Beta | 1.08 | 0.90 | 0.92 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.48 on 11/13/24 | -0.20 on 11/13/24 | 0.00 on 10/31/24 | ||
| Latest Earnings Date | 11/14/24 | 11/13/24 | 10/31/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||